Education
About Us
Working with TipRanks
Follow Us
Becton Dickinson And Company (BDX)
NYSE:BDX
BDX Stock Chart & Stats
$190.96
$1.03(0.44%)
At close: 4:00 PM EST
$190.96
$1.03(0.44%)
Day’s Range― - ―
52-Week Range$162.29 - $251.99
Previous CloseN/A
Volume443.35K
Average Volume (3M)2.59M
Market Cap
$55.24B
Enterprise Value$72.06B
Total Cash (Recent Filing)$859.00M
Total Debt (Recent Filing)$19.18B
Price to Earnings (P/E)33.1
Beta0.39
Next Earnings
Jan 29, 2026EPS Estimate
2.81Last Dividend Ex-Date
Sep 08, 2025Dividend Yield2.35%
Share Statistics
EPS (TTM)3.96
Shares Outstanding286,627,470
10 Day Avg. Volume2,799,858
30 Day Avg. Volume2,589,885
Financial Highlights & Ratios
PEG Ratio-47.00
Price to Book (P/B)0.00
Price to Sales (P/S)2.46
P/FCF Ratio20.09
Enterprise Value/Market Cap1.30
Enterprise Value/Revenue3.30
Enterprise Value/Gross Profit7.26
Enterprise Value/Ebitda14.54
Forecast
1Y Price Target
$193.71Price Target Upside1.44% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering7
EPS Forecast (FY)14.86
Revenue Forecast (FY)$22.78B
Bulls Say, Bears Say
Bulls Say
EarningsBDX announced preliminary F4Q revenue of $5.9B, representing 3.9% organic growth.
Segment PerformanceBDX's Interventional segment sales of $1.37B beat the Street's $1.35B target and were up 7.5% CC.
Share BuybackIt is estimated that $2 billion of proceeds will be deployed toward share buyback, reducing share count.
Bears Say
International HeadwindsChina is a 100bps headwind on full year, with BDX taking a more conservative view on China (now saying down mid-teens vs prior saying down high single digits).
Leadership ChangesThe departure of CFO Chris DelOrefice is seen as a negative factor, especially since it occurs ahead of the new long-range plan.
Market CredibilityBDX missed its Q4 revenue expectations, which has led to concerns about the company's credibility.
Becton Dickinson News
BDX FAQ
What was Becton Dickinson And Company’s price range in the past 12 months?
Becton Dickinson And Company lowest stock price was $162.29 and its highest was $251.99 in the past 12 months.
What is Becton Dickinson And Company’s market cap?
Becton Dickinson And Company’s market cap is $55.24B.
When is Becton Dickinson And Company’s upcoming earnings report date?
Becton Dickinson And Company’s upcoming earnings report date is Jan 29, 2026 which is in 64 days.
How were Becton Dickinson And Company’s earnings last quarter?
Becton Dickinson And Company released its earnings results on Nov 06, 2025. The company reported $3.96 earnings per share for the quarter, beating the consensus estimate of $3.919 by $0.041.
Is Becton Dickinson And Company overvalued?
According to Wall Street analysts Becton Dickinson And Company’s price is currently Undervalued.
Does Becton Dickinson And Company pay dividends?
Becton Dickinson And Company pays a Quarterly dividend of $1.04 which represents an annual dividend yield of 2.35%. See more information on Becton Dickinson And Company dividends here
What is Becton Dickinson And Company’s EPS estimate?
Becton Dickinson And Company’s EPS estimate is 2.81.
How many shares outstanding does Becton Dickinson And Company have?
Becton Dickinson And Company has 286,627,470 shares outstanding.
What happened to Becton Dickinson And Company’s price movement after its last earnings report?
Becton Dickinson And Company reported an EPS of $3.96 in its last earnings report, beating expectations of $3.919. Following the earnings report the stock price went up 0.567%.
Which hedge fund is a major shareholder of Becton Dickinson And Company?
Currently, no hedge funds are holding shares in BDX
Becton Dickinson Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$193.71 (1.44% Upside)
$193.71 (1.44% Upside)
Blogger Sentiment
Bullish
BDX Sentiment 80%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Increased
By 88.8K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $210.3K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 0.6%
Last 30 Days ▼ 2.0%
Last 30 Days ▼ 2.0%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-12.72%
12-Months-Change
Fundamentals
Return on Equity
6.54%
Trailing 12-Months
Asset Growth
-3.42%
Trailing 12-Months
Company Description
Becton Dickinson And Company
Becton Dickinson (BDX) is a global medical technology company that focuses on advancing the world of health by providing innovative solutions that help healthcare professionals improve patient outcomes. Established in 1897, BDX operates in three primary sectors: BD Medical, BD Life Sciences, and BD Interventional. The company's core products include needles, syringes, and infusion systems in the BD Medical segment, diagnostic instruments and reagents in the BD Life Sciences segment, and various interventional devices in the BD Interventional segment. BDX is dedicated to enhancing the safety, quality, and efficiency of healthcare delivery worldwide.
BDX Company Deck
BDX Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
BD reported strong revenue and earnings growth, driven by high-performing segments like BD Interventional and Advanced Patient Monitoring. Operational efficiencies and strategic initiatives position BD for future growth. However, challenges such as declining vaccine demand, China market dynamics, and Alaris headwinds pose significant hurdles.View all BDX earnings summariesBDX Revenue Breakdown
57.80% U.S.
21.82% EMEA
14.40% Greater Asia
5.98% Other
BDX Stock 12 Month Forecast
Average Price Target
$193.71
▲(1.44% Upside)
Technical Analysis
Baxter International
―
Hologic
―
Intuitive Surgical
―
Resmed
―
West Pharmaceutical Services
―
Ownership Overview
0.14% Insiders
32.45% Mutual Funds
13.23% Other Institutional Investors
29.83% Public Companies and Individual Investors